This inventor holds 2 USPTO granted patents and 1 published patent application and 1 EPO patent. Top assignees: Calchan Limited, Convergence Pharmaceuticals Limited. Active years: 2015-2017.
Company Filing History:
Years Active: 2015-2017
Title: Mairi Sime: Innovator in Pyrrolopyrimidine Derivatives
Introduction
Mairi Sime is a distinguished inventor based in Cambridge, GB. She has made significant contributions to the field of pharmaceuticals, particularly through her innovative work on pyrrolopyrimidine derivatives. With a total of 2 patents, her inventions are paving the way for advancements in medical treatments.
Latest Patents
Mairi's latest patents focus on ASK1 inhibiting pyrrolopyrimidine derivatives. These inventions relate to pyrrolopyrimidine derivatives of formula (I), where R, X, p, R, and R are defined within the patent documentation. The applications of these derivatives are primarily in the pharmaceutical sector, showcasing their potential in developing new therapeutic agents.
Career Highlights
Throughout her career, Mairi has worked with notable companies such as Convergence Pharmaceuticals Limited and Calchan Limited. Her experience in these organizations has allowed her to refine her expertise and contribute to groundbreaking research in her field.
Collaborations
Mairi has collaborated with esteemed colleagues, including David Witty and David Norton. These partnerships have further enhanced her research and development efforts, leading to innovative solutions in pharmaceuticals.
Conclusion
Mairi Sime's contributions to the field of pharmaceuticals through her patents on pyrrolopyrimidine derivatives highlight her role as a key innovator. Her work continues to inspire advancements in medical treatments and showcases the importance of collaboration in research.